Intrinsiqs

Is Collegium Pharmaceutical, Inc. overvalued?

Collegium Pharmaceutical, Inc. (COLL) — key valuation metrics and fundamentals.

No verdict
Price
$25.32
Fair value
—
Current P/E
—
Normal P/E
21.6
Market cap
$786.8M
Dividend yield
0.0%
Return on equity
12.5%
Sector
Healthcare

See the full interactive analysis →

Fair value compares COLL's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.